These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 32496660)
1. Central serous chorioretinopathy secondary to subtenon triamcinolone injection: A new hypothesis for the mechanism. Dhanji S; Fung AT Clin Exp Ophthalmol; 2020 Sep; 48(7):1007-1009. PubMed ID: 32496660 [No Abstract] [Full Text] [Related]
2. Bilateral and multifocal central serous chorioretinopathy after injecting triamcinolone into a chalazion. Asensio-Sánchez VM; Pareja-Aricó L; Valentín-Bravo J Arch Soc Esp Oftalmol (Engl Ed); 2020 Mar; 95(3):141-145. PubMed ID: 32001028 [TBL] [Abstract][Full Text] [Related]
3. A potential side effect of oral topical steroids: Central serous chorioretinopathy. George S; Balan A Indian J Dent Res; 2018; 29(1):107-108. PubMed ID: 29442094 [TBL] [Abstract][Full Text] [Related]
4. Central serous chorioretinopathy following vitrectomy with intravitreal triamcinolone acetonide for diabetic macular oedema. Imasawa M; Ohshiro T; Gotoh T; Imai M; Iijima H Acta Ophthalmol Scand; 2005 Feb; 83(1):132-3. PubMed ID: 15715582 [No Abstract] [Full Text] [Related]
5. Acute central serous chorioretinopathy following subconjunctival triamcinolone acetonide injection in cataract surgery (less drop approach) - A case series. Aravind H; Rajendran A; Baskaran P; Lobo S; Vempati J; Anthony E Indian J Ophthalmol; 2022 Mar; 70(3):1066-1068. PubMed ID: 35225580 [No Abstract] [Full Text] [Related]
6. Intravitreal versus posterior subtenon injection of triamcinolone acetonide for diabetic macular edema. Choi YJ; Oh IK; Oh JR; Huh K Korean J Ophthalmol; 2006 Dec; 20(4):205-9. PubMed ID: 17302204 [TBL] [Abstract][Full Text] [Related]
8. Intranasal Corticosteroids and Central Serous Chorioretinopathy: A Report and Review of the Literature. Nakatsuka AS; Khanamiri HN; Lam QN; El-Annan J Hawaii J Med Public Health; 2019 May; 78(5):151-154. PubMed ID: 31049263 [TBL] [Abstract][Full Text] [Related]
9. Prospective study of intravitreal triamcinolone acetonide versus bevacizumab for macular edema secondary to central retinal vein occlusion. Ding X; Li J; Hu X; Yu S; Pan J; Tang S Retina; 2011 May; 31(5):838-45. PubMed ID: 21293319 [TBL] [Abstract][Full Text] [Related]
10. Serous macular detachment as a predictor of resolution of macular edema with intravitreal triamcinolone injection. Shukla D; Behera UC; Chakraborty S; Mahalakshmi R; Prasad NM Ophthalmic Surg Lasers Imaging; 2009; 40(2):115-9. PubMed ID: 19320299 [TBL] [Abstract][Full Text] [Related]
11. Posterior subtenon injection of triamcinolone acetonide after phacoemulsification in a patient with X-linked retinoschisis. Wang JK; Lin WC Optom Vis Sci; 2013 Oct; 90(10):e274-7. PubMed ID: 23974665 [TBL] [Abstract][Full Text] [Related]
12. Short-term outcomes of subtenon triamcinolone acetonide injections in patients with retinitis pigmentosa-associated cystoid macular edema unresponsive to carbonic anhydrase inhibitors. Karasu B Int Ophthalmol; 2020 Mar; 40(3):677-687. PubMed ID: 31773389 [TBL] [Abstract][Full Text] [Related]
13. Two-year results of intravitreal triamcinolone acetonide injection for the treatment of macular edema due to central retinal vein occlusion. Batioglu F; Ozmert E; Akmese E Ann Ophthalmol (Skokie); 2007; 39(4):307-12. PubMed ID: 18025651 [TBL] [Abstract][Full Text] [Related]
14. A case of herpetic epithelial keratitis after triamcinolone acetonide subtenon injection. Hashizume K; Nabeshima T; Fujiwara T; Machida S; Kurosaka D Cornea; 2009 May; 28(4):463-4. PubMed ID: 19411969 [TBL] [Abstract][Full Text] [Related]
15. Sterile endophthalmitis following intravitreal triamcinolone acetonide in July 2010. Kim M; Yu SY; Kwak HW Indian J Ophthalmol; 2015 May; 63(5):467-8. PubMed ID: 26139818 [No Abstract] [Full Text] [Related]